Great write up! I have been a hold for >6 years
Agree with the lack of conviction/execution by management. They have not been able to get the same level of traction on iTrack sales like Glaukos. Management are always saying Glaukos have more sales staff, hence more sales, but they are heavily loss making.I think one of the reasons iStent is more popular is because its simpler and faster to perform. Perhaps they might be able to grow iTrack sales faster with the updated procedure which is said to address the speed issue and also it has been highlighted in a study that iTrack is safer than iStent.There is clearly a market for multiple MIGS procedures and iTrack could continue to steadily grow sales.
I was happy to learn on the results call the reason why 2RT is not getting any sales traction in Europe i.e. it is approved for sale there. Physicians want to see more data/trials before using it and so they haven't invested in the sales infrastructure in Europe yet. This will likely be done after the trial completes in the US if successful, which is still a few years away. Overall, this is a Hold for me. iTrack is the steady earner (not sure how much Molteno will grow). 2RT could be a game changer.
- Forums
- ASX - By Stock
- Ann: FY20 Results presentation
Great write up! I have been a hold for >6 yearsAgree with the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $44.66M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 19.5¢ | $9.907K | 50.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65104 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 169956 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65104 | 0.195 |
3 | 202141 | 0.190 |
2 | 120980 | 0.185 |
2 | 71691 | 0.180 |
5 | 114937 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 169956 | 5 |
0.205 | 44282 | 2 |
0.210 | 223212 | 2 |
0.215 | 354291 | 5 |
0.230 | 103718 | 2 |
Last trade - 13.43pm 13/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online